Apolipoprotein AI- and AI:AII-containing lipoproteins in white men and women of the HERITAGE Family Study: Associations with metabolic risk profile variables

Metabolism: Clinical and Experimental

Volumn 52, Issue 12, 2003, Pages 1530-1536

  Couillard, Charles ^{a,b,c,d,e,f,g,h}   Bergeron, Jean ^{a,b,c,d,e,f,g,h}   Després, Jean Pierre ^{a,b,c,d,e,f,g,h}   Gagnon, Jacques ^{a,b,c,d,e,f,g,h}   Rankinen, Tuomo ^{a,b,c,d,e,f,g,h}   Leon, Arthur S ^{a,b,c,d,e,f,g,h}   Rao, D C ^{a,b,c,d,e,f,g,h}   Skinner, James S ^{a,b,c,d,e,f,g,h}   Wilmore, Jack H ^{a,b,c,d,e,f,g,h}   Bouchard, Claude ^{a,b,c,d,e,f,g,h}  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c LAVAL UNIVERSITY   (Canada)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^e UNIVERSITY OF MINNESOTA   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g INDIANA UNIVERSITY   (United States)

^h TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN;

ABDOMEN; ADIPOSE TISSUE; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY COMPOSITION; BODY DISTRIBUTION; BODY FAT; BODY MASS; CAUCASIAN; CHOLESTEROL BLOOD LEVEL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIET RESTRICTION; DISORDERS OF LIPOPROTEIN METABOLISM; FAMILY; FEMALE; GENDER; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; PREMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

EID: 9144273791     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2003.07.003     Document Type: Article

References (35)

1. Castelli WP: Epidemiology of coronary heart disease: The Framingham study. Am J Med 76:4-12, 1984
2. Castelli WP, Garrison RJ, Wilson PW, et al: Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 256:2835-2838, 1986
3. Assmann G, Schulte H: Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Munster study. Am J Cardiol 70:733-737, 1992
4. Jeppesen J, Hein HO, Suadicani P, et al: Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study. Arterioscler Thromb Vasc Biol 17:1114-1120, 1997
5. Fruchart JC, Ailhaud G: Apolipoprotein A-containing lipoprotein particles: Physiological role, quantification, and clinical significance. Clin Chem 38:793-797, 1992
6. Laakso M, Voutilainen E, Pyörälä K, et al: Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics. Arteriosclerosis 5:653-658, 1985
7. Laakso M, Lehto S, Penttila I, et al: Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin-dependent diabetes. Circulation 88:1421-1430, 1993
8. Von Eckardstein A, Huang Y, Assmann G: Physiological role and clinical relevance of high-density lipoprotein subclasses. Curr Opin Lipidol 5:404-416, 1994
9. Cheung MC, Albers JJ: Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II. J Biol Chem 259:12201-12209, 1984
10. Puchois P, Kandoussi A, Fievet P, et al: Apolipoprotein A-I containing lipoproteins in coronary artery disease. Atherosclerosis 68:35-40, 1987
11. Cheung MC, Brown BG, Wolf AC, et al: Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. J Lipid Res 32:383-394, 1991
12. Bouchard C, Leon AS, Rao DC, et al: The HERITAGE Family Study. Aims, design, and measurement protocol. Med Sci Sports Exerc 27:721-729, 1995
13. The Airlie (VA) Consensus Conference: Standardization of Anthropometric Measurements. Lohman T, Roche A, Martorel R. Champaign, IL, Human Kinetics, Publ. 20-37, 1988
14. Van Der Kooy K, Seidell JC: Techniques for the measurement of visceral fat: A practical guide. Int J Obes 17: 187-196, 1993
15. Behnke AR, Wilmore JH: Evaluation and Regulation of Body Build and Composition. Englewood Cliffs, NJ, Prentice-Hall, 1974
16. Siri WE: Body composition from fluid spaces and density: Analysis of methods, in Brozek J, Henschel A (eds): Techniques for Measuring Body Composition. Washington, DC, National Academy of Sciences, National Research Council, 1961, pp 223-224
17. Lohman TG: Applicability of body composition techniques and constants for children and youths. Exerc Sport Sci Rev 14:325-357, 1986
18. Wilmore JH, Stanforth PR, Domenick MA, et al: Reproducibility of anthropometric and body composition measurements: The HERITAGE Family Study. Int J Obes 21:297-303, 1997
19. Després JP, Prud'homme D, Pouliot MC, et al: Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 54:471-477, 1991
20. Ferland M, Després JP, Tremblay A, et al: Assessment of adipose tissue distribution by computed axial tomography in obese women: Association with body density and anthropometric measurements. Br J Nutr 61:139-148, 1989
21. Moorjani S, Dupont A, Labrie F, et al: Increase in plasma high-density lipoprotein concentration following complete androgen blockage in men with prostatic carcinoma. Metabolism 36:244-250, 1987
22. Burstein M, Scholnick HR, Morfin R: Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 11:583-595, 1970
23. Gidez LI, Miller GJ, Burstein M, et al: Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure. J Lipid Res 23:1206-1223, 1982
24. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 15:45-52, 1966
25. Avogaro P, Bon GB, Cazzolato G, et al: Are apolipoproteins better discriminators than lipids for atherosclerosis? Lancet 1:901-903, 1979
26. Després JP, Gagnon J, Bergeron J, et al: Plasma post-heparin lipase activities in the HERITAGE Family Study - The reproducibility, gender differences and associations with lipoprotein levels. Clin Biochem 32:157-165, 1999
27. Desbuquois B, Aurbach GD: Use of polyethylene glycol to separate free and antibody-bound peptide hormones in radioimmuno-assays. J Clin Endocrinol Metab 33:732-738, 1971
28. Roder ME, Porte D Jr, Schwartz RS, et al: Disproportionately elevated proinsulin levels reflect the degree of impaired B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:604-608, 1998
29. Wilson PW, D'Agostino RB, Levy D, et al: Prediction of coronary heart disease using risk factor categories. Circulation 97:1837-1847, 1998
30. Després JP, Couillard C, Gagnon J, et al: Race, visceral adipose tissue, plasma lipids and lipoprotein lipase activity in men and women - The HERITAGE Family Study. Arterioscler Thromb Vasc Biol 20:1932-1938, 2000
31. Leon AS, Rice T, Mandel S, et al: Blood lipid response to 20 weeks of supervised exercise in a large biracial population: The HERITAGE Family Study. Metabolism 49:513-520, 2000
32. Bard JM, Fruchart JC: HDL particle measurements: Impact for diagnosis and therapy. Clin Biochem 26:65-68, 1993
33. Barter PJ, Rye KA: High density lipoproteins and coronary heart disease. Atherosclerosis 121:1-12, 1996
34. Lecerf JM, Masson A, Fruchart JC, et al: Serum Lp AI lipoprotein particles and other antiatherogenic lipid parameters in normolipidaemic obese subjects. Diabetes Metab 22:331-340, 1996
35. Asztalos BF, Roheim PS, Milani RL, et al: Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease. Arterioscler Thromb Vasc Biol 20:2670-2676, 2000